Shandong Buchang Pharmaceuticals Co., Ltd. (SHA:603858)

China · Delayed Price · Currency is CNY

15.43

-0.24 (-1.53%)

May 20, 2026, 11:29 AM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2018	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Jan '18 Jan 1, 2018	Dec '16 Dec 31, 2016
Pharmaceutical Divison	9.30B	-	-					12.53B
Offset of Business Segment	-1.35B	-	-					-1.37B
Pharmaceutical Sales	2.00B	-	-					2.61B
Other Operations	1.05B	-	-					94.42M
Total	11.01B	-	-					13.86B

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2018	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Jan '18 Jan 1, 2018	Dec '16 Dec 31, 2016
Northeast Region	1.23B	-	-					-
North China Region	2.14B	-	-					-
East China Region	2.90B	-	-					-
Central China Region	2.25B	-	-					-
Northwest Region	1.35B	-	-					-
Southwest Region	1.09B	-	-					-
Export	14.40M	-	-					-
Total	10.97B	-	-					-

Source: S&P Global Market Intelligence.